Hamburg looks to restructure FDA for consistency
This article was originally published in The Silver Sheet
Executive Summary
FDA Commissioner Margaret Hamburg says she wants to restructure the agency's front office to be more "internally consistent," according to a June 29 memo obtained by Elsevier Business Intelligence. "Various programs in the Office of the Commissioner are sited across that organization with little underlying rationale for their placement," the commissioner writes in a reorganization proposal to Health and Human Services leadership. The memo lays out a plan to streamline the development of the agency's budget, refine the chief scientist's mission and create new offices to fill gaps and bring related activities in closer contact. The proposal would not impact the structure or leadership of CDRH. The affected office with perhaps the most device-specific responsibilities is the Office of Combination Products, which would no longer report to the agency's chief scientist, but instead move to a new Office of Special Medical Programs focused exclusively on "cross-cutting medical programs.
You may also be interested in...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.